These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The emerging role of serine proteases in apoptosis. Moffitt KL; Martin SL; Walker B Biochem Soc Trans; 2007 Jun; 35(Pt 3):559-60. PubMed ID: 17511651 [TBL] [Abstract][Full Text] [Related]
26. From tadpole tails to transgenic mice: metalloproteinases have brought about a metamorphosis in our understanding of cardiovascular disease. Newby AC; Pauschinger M; Spinale FG Cardiovasc Res; 2006 Feb; 69(3):559-61. PubMed ID: 16427036 [No Abstract] [Full Text] [Related]
27. [Women and autoimmune diseases with cardiovascular manifestations]. Portig I; Sandmöller A; Pankuweit S; Maisch B Herz; 2005 Sep; 30(6):522-6. PubMed ID: 16170683 [TBL] [Abstract][Full Text] [Related]
28. Nonspecific cytotoxic cells of teleosts are armed with multiple granzymes and other components of the granule exocytosis pathway. Praveen K; Leary JH; Evans DL; Jaso-Friedmann L Mol Immunol; 2006 Mar; 43(8):1152-62. PubMed ID: 16137766 [TBL] [Abstract][Full Text] [Related]
29. On the roles of extracellular matrix remodeling by gelatinase B. Opdenakker G Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820 [TBL] [Abstract][Full Text] [Related]
30. The aging spine: the role of inflammatory mediators in intervertebral disc degeneration. Podichetty VK Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):4-18. PubMed ID: 17543240 [TBL] [Abstract][Full Text] [Related]
32. The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Bruunsgaard H Dan Med Bull; 2006 Aug; 53(3):285-309. PubMed ID: 17092450 [No Abstract] [Full Text] [Related]
34. Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. Froelich CJ; Zhang X; Turbov J; Hudig D; Winkler U; Hanna WL J Immunol; 1993 Dec; 151(12):7161-71. PubMed ID: 8258716 [TBL] [Abstract][Full Text] [Related]
35. Aging of the immune system: a risk factor for autoimmunity? Prelog M Autoimmun Rev; 2006 Feb; 5(2):136-9. PubMed ID: 16431345 [TBL] [Abstract][Full Text] [Related]
38. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Rabinovich GA; Liu FT; Hirashima M; Anderson A Scand J Immunol; 2007; 66(2-3):143-58. PubMed ID: 17635792 [TBL] [Abstract][Full Text] [Related]
39. Complement in lung disease. Sarma VJ; Huber-Lang M; Ward PA Autoimmunity; 2006 Aug; 39(5):387-94. PubMed ID: 16923538 [TBL] [Abstract][Full Text] [Related]
40. The target tissue in autoimmunity--an influential niche. Hill NJ; Hultcrantz M; Sarvetnick N; Flodström-Tullberg M Eur J Immunol; 2007 Mar; 37(3):589-97. PubMed ID: 17301949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]